Sublingual Immunotherapy (SLIT) Quality of Life Outcomes

Even though the South Carolina study indicated that SLIT is effective in controlling allergic symptoms and is safe in an introductory patient sample, Dr. Wise and the study’s senior author, Rodney J. Schlosser, MD, MUSC Associate Professor of Otolaryngology, suggest that double-blind, placebo-controlled trials are needed to confirm their preliminary results.

We also need to determine if monotherapy or polytherapy is best, Dr. Wise said. And we need to look at dosing regimens, escalation and maintenance schedules, and provide an evaluation of immunologic changes.

©2007 The Triological Society